These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 8527842)

  • 21. Clinical applications of hematopoietic growth factors in pediatric oncology.
    Levine JE; Boxer LA
    Curr Opin Hematol; 2002 May; 9(3):222-7. PubMed ID: 11953668
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of hematopoietic growth factors in the treatment of neoplastic diseases.
    St Onge J; Jacobson RJ
    Semin Hematol; 1992 Jul; 29(3 Suppl 2):53-63. PubMed ID: 1380737
    [No Abstract]   [Full Text] [Related]  

  • 23. Thrombopoietic factors potentially useful in the treatment of acute leukemia.
    Archimbaud E; Thomas X
    Leuk Res; 1998 Dec; 22(12):1155-64. PubMed ID: 9922079
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Hematopoietic growth factors and autologous or allogeneic stem cell transplantation].
    Bay JO; Peffault de Latour R; Tournilhac O; Choufi B; Chassagne J
    Bull Cancer; 2006 May; 93(5):473-82. PubMed ID: 16777625
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of peritransplant administration of hematopoietic growth factors on the development of chronic allograft rejection.
    Terakura M; Ye Q; Ichikawa N; Demetris AJ; Sakamoto T; Liu Z; Starzl TE; Murase N
    Transplant Proc; 1999; 31(1-2):870-1. PubMed ID: 10083380
    [No Abstract]   [Full Text] [Related]  

  • 26. Regulatory issues involved in hematopoietic growth factor approval.
    Zoon KC; Cohen RB; Gerrard T
    Semin Oncol; 1992 Aug; 19(4):432-40. PubMed ID: 1380733
    [No Abstract]   [Full Text] [Related]  

  • 27. The role of granulocyte-macrophage colony-stimulating factor-stimulated progenitor cells in oncology.
    Rosenfeld CS; Nemunaitis J
    Semin Hematol; 1992 Oct; 29(4 Suppl 3):19-26. PubMed ID: 1362822
    [No Abstract]   [Full Text] [Related]  

  • 28. Cytokine-mobilized peripheral blood progenitor cells.
    Nemunaitis J
    Semin Oncol; 1996 Apr; 23(2 Suppl 4):9-14. PubMed ID: 8600547
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Factors affecting the mobilization of primitive and committed hematopoietic progenitors into the peripheral blood of cancer patients.
    Schneider JG; Crown JP; Wasserheit C; Kritz A; Wong G; Reich L; Norton L; Moore MA
    Bone Marrow Transplant; 1994 Dec; 14(6):877-84. PubMed ID: 7536069
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human hematopoietic growth factors: old lessons and new perspectives.
    Dempke W; Von Poblozki A; Grothey A; Schmoll HJ
    Anticancer Res; 2000; 20(6D):5155-64. PubMed ID: 11326688
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Myelopoietic growth factors after stem cell transplantation: does it pay.
    Cairo MS
    J Pediatr Hematol Oncol; 2001 Jan; 23(1):2-6. PubMed ID: 11196265
    [No Abstract]   [Full Text] [Related]  

  • 32. Cytokines in anticancer therapy.
    Khan IU; Shear NH
    Clin Dermatol; 1991; 9(4):523-33. PubMed ID: 1726586
    [No Abstract]   [Full Text] [Related]  

  • 33. Aspects on the clinical use of hematopoietic growth factors in myelodysplastic syndromes.
    Hast R; Eriksson M; Jakovleva K
    Pol Arch Med Wewn; 1998 Feb; 99(2):144-9. PubMed ID: 9686516
    [No Abstract]   [Full Text] [Related]  

  • 34. Clinical uses of hematopoietic growth hormones in HIV-related illnesses.
    Mitsuyasu RT
    AIDS Clin Rev; 1993-1994; ():189-212. PubMed ID: 7692940
    [No Abstract]   [Full Text] [Related]  

  • 35. The role of haematopoietic growth factors in bone marrow transplantation.
    Polli EE
    Acta Haematol; 1991; 86(3):155-61. PubMed ID: 1723825
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Platelet growth factors: potential impact on transfusion medicine.
    Kuter DJ; Cebon J; Harker LA; Petz LD; McCullough J
    Transfusion; 1999 Mar; 39(3):321-32. PubMed ID: 10204598
    [No Abstract]   [Full Text] [Related]  

  • 37. Haemopoietic growth factors for neonates: assessing risks and benefits.
    Carr R; Modi N
    Acta Paediatr Suppl; 2004 Feb; 93(444):15-9. PubMed ID: 15035456
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of recombinant stem cell factor on clonogenic maturation and cycle status of human fetal hematopoietic progenitors.
    Schibler KR; Ohls RK; Le T; Liechty KW; Christensen RD
    Pediatr Res; 1994 Mar; 35(3):303-6. PubMed ID: 7514781
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical applications of hematopoietic growth factors.
    Vose JM; Armitage JO
    J Clin Oncol; 1995 Apr; 13(4):1023-35. PubMed ID: 7535842
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical applications of haemopoietic growth factors.
    Khwaja A; Linch DC
    Leuk Lymphoma; 1992; 7 Suppl():69-72. PubMed ID: 1283549
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.